Reverse Medical said that the RePort Guide Catheter System provides the neurovascular specialist with a new tool that can navigate deeply into the cerebral vascular anatomy, enabling them to treat more patients than with currently available technologies.
The California-based neurovascular devices firm has been working to expand its technology platform to include treatments for a broad spectrum of neurovascular disorders and carotid artery disease.
Satoshi Tateshima, scientific and clinical advisor of Reverse Medical, UCLA Interventional Neuroradiology, Ronald Reagan UCLA Medical Center, said: “The neurovascular anatomy often presents challenges related to fundamental access, and deep brain therapeutic microcatheter navigation support.
“The RePort Guide Catheter System design represents a game changing advancement over other guide catheters available today. The system is designed to be used across a broad range of neuro interventional procedures.
“The RePort Guide Catheter System has been designed to enable placement beyond the skull base more easily and safely than other currently available devices. I look forward to its US commercial availability in the future.”
Jeffrey Valko, president and chief executive officer of Reverse Medical, said: “The timing for the RePort Guide Catheter System regulatory approval is perfect as access to the deep neurovascular anatomy is a current focus of neuro interventionalists’ interest.
“The various RePort Guide Catheter System models will enable physicians to treat a broader group of patients, helping to increase patient throughput and to enhance the economic viability of neuro labs and stroke centers worldwide. The company plans to commence commercialization during 2010.”
